Cargando…

Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19

Point of care detection of SARS-CoV-2 is one pillar in a containment strategy and important to break infection chains. Here we report the sensitive, specific and robust detection of SARS-CoV-2 and respective variants of concern by the ID NOW COVID-19 device.

Detalles Bibliográficos
Autores principales:	Krause, Eva, Puyskens, Andreas, Bourquain, Daniel, Brinkmann, Annika, Biere, Barbara, Schaade, Lars, Michel, Janine, Nitsche, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105142/ https://www.ncbi.nlm.nih.gov/pubmed/33971264 http://dx.doi.org/10.1016/j.mcp.2021.101742

Ejemplares similares

Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2
por: Michel, Janine, et al.
Publicado: (2021)

Flexible upscaling of laboratory PCR testing capacity at the Robert Koch Institute during the SARS-CoV-2 pandemic
por: Krause, Eva, et al.
Publicado: (2023)

Extensive ITR expansion of the 2022 Mpox virus genome through gene duplication and gene loss
por: Brinkmann, Annika, et al.
Publicado: (2023)

Performance of 20 rapid antigen detection tests to detect SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variants using a clinical specimen panel from January 2022, Berlin, Germany
por: Puyskens, Andreas, et al.
Publicado: (2023)

Evaluation of 11 commercially available PCR kits for the detection of monkeypox virus DNA, Berlin, July to September 2022
por: Michel, Janine, et al.
Publicado: (2022)

Replication of cowpox virus in macrophages is dependent on the host range factor p28/N1R
por: Bourquain, Daniel, et al.
Publicado: (2021)

Direct comparison of clinical diagnostic sensitivity of saliva from buccal swabs versus combined oro-/nasopharyngeal swabs in the detection of SARS-CoV-2 B.1.1.529 Omicron
por: Puyskens, Andreas, et al.
Publicado: (2023)

Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021
por: Puyskens, Andreas, et al.
Publicado: (2021)

RespiCoV: Simultaneous identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and 46 respiratory tract viruses and bacteria by amplicon-based Oxford-Nanopore MinION sequencing
por: Brinkmann, Annika, et al.
Publicado: (2022)

AmpliCoV: Rapid Whole-Genome Sequencing Using Multiplex PCR Amplification and Real-Time Oxford Nanopore MinION Sequencing Enables Rapid Variant Identification of SARS-CoV-2
por: Brinkmann, Annika, et al.
Publicado: (2021)

An intra-host SARS-CoV-2 dynamics model to assess testing and quarantine strategies for incoming travelers, contact management, and de-isolation
por: van der Toorn, Wiep, et al.
Publicado: (2021)

Fast and reliable real life data on COVID-19 triaging with ID NOW
por: Burdino, Elisa, et al.
Publicado: (2022)

Sensitivity of ID NOW and RT–PCR for detection of SARS-CoV-2 in an ambulatory population
por: Tu, Yuan-Po, et al.
Publicado: (2021)

Cowpox virus but not Vaccinia virus induces secretion of CXCL1, IL-8 and IL-6 and chemotaxis of monocytes in vitro
por: Bourquain, Daniel, et al.
Publicado: (2013)

Puumala and Tula Virus Differ in Replication Kinetics and Innate Immune Stimulation in Human Endothelial Cells and Macrophages
por: Bourquain, Daniel, et al.
Publicado: (2019)

Evaluation of a commercial ELISA as alternative to plaque reduction neutralization test to detect neutralizing antibodies against SARS-CoV-2
por: Hofmann, Natalie, et al.
Publicado: (2022)

Comparison of the Cowpox Virus and Vaccinia Virus Mature Virion Proteome: Analysis of the Species- and Strain-Specific Proteome
por: Doellinger, Joerg, et al.
Publicado: (2015)

Comparison of host cell gene expression in cowpox, monkeypox or vaccinia virus-infected cells reveals virus-specific regulation of immune response genes
por: Bourquain, Daniel, et al.
Publicado: (2013)

Application of spectral library prediction for parallel reaction monitoring of viral peptides
por: Grossegesse, Marica, et al.
Publicado: (2021)

Evaluation of the COVID19 ID NOW EUA assay
por: Mitchell, Stephanie L., et al.
Publicado: (2020)

Evaluating the Ability to ID (COVID-19) NOW: a Large Real-World Prospective Evaluation of the Abbott ID NOW COVID-19 Assay
por: Barker, K. R., et al.
Publicado: (2022)

Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021
por: Scheiblauer, Heinrich, et al.
Publicado: (2021)

Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022
por: Stoliaroff-Pepin, Anna, et al.
Publicado: (2023)

Combined Proteomics/Genomics Approach Reveals Proteomic Changes of Mature Virions as a Novel Poxvirus Adaptation Mechanism
por: Grossegesse, Marica, et al.
Publicado: (2017)

A Next-Generation Sequencing Approach Uncovers Viral Transcripts Incorporated in Poxvirus Virions
por: Grossegesse, Marica, et al.
Publicado: (2017)

Morphometry of SARS-CoV and SARS-CoV-2 particles in ultrathin plastic sections of infected Vero cell cultures
por: Laue, Michael, et al.
Publicado: (2021)

Diagnostic Approach for the Differentiation of the Pandemic Influenza A(H1N1)v Virus from Recent Human Influenza Viruses by Real-Time PCR
por: Schulze, Martin, et al.
Publicado: (2010)

Viral Metagenomics on Blood-Feeding Arthropods as a Tool for Human Disease Surveillance
por: Brinkmann, Annika, et al.
Publicado: (2016)

Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting
por: Graham, Maryza, et al.
Publicado: (2021)

Where Are They Now? A Case Study of Health-related Web Site Attrition
por: Veronin, Michael A
Publicado: (2002)

Abbott ID NOW™ COVID-19 assay: do not discard the swab
por: MacDonald, Clayton, et al.
Publicado: (2023)

One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™
por: Burnes, Laura E, et al.
Publicado: (2021)

678. Rapid Molecular SARS-CoV-2 Detection by Abbott ID NOW Is Reliable in Pediatric Patients
por: Murphy, Catherine, et al.
Publicado: (2021)

Gene gun-supported DNA immunisation of chicken for straightforward production of poxvirus-specific IgY antibodies
por: Witkowski, Peter T., et al.
Publicado: (2009)

The ID NOW COVID-19, a high-speed high-performance assay
por: Farfour, Eric, et al.
Publicado: (2021)

Abbott ID now COVID-19 assay performance: a year in review
por: Thwe, Phyu M., et al.
Publicado: (2021)

Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2
por: Smithgall, Marie C., et al.
Publicado: (2020)

Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions
por: Barnacle, J.R., et al.
Publicado: (2022)

Application of Abbott ID NOW in the emergency department for SARS-CoV-2 detection: A medical center’s perspective
por: Fan, Shu-Ling
Publicado: (2023)

Visualization of SARS-CoV-2 particles in naso/oropharyngeal swabs by thin section electron microscopy
por: Laue, Michael, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0p29etej3lekeqe1n7mcevf620